Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously ...

Daraxonrasib is the first investigational agent in a novel class of RAS (ON) multi-selective inhibitors designed to address a diverse and broad spectrum of RAS variants. In the randomized Phase 3 ...

JD.com’s Apple Flagship Store Reaches 100 Million Followers

On May 26, JD.com’s self-operated Apple products flagship store reached a major milestone, surpassing 100 million followers ...

A New Chapter Is Emerging in Pakistan-China Relations

That transition may ultimately define the next chapter of Pakistan-China relations. The first phase focused on building physical connectivity across regions. The next phase appears focused on building ...

Apex Trader Funding: 90% Off, New 5-Pack Bundles & No Activation Fees Plan Launched

New York, USA, May 29th, 2026, FinanceWireApex Trader Funding has announced one of its promotional campaigns offering up to ...
Business Insider

Innovator Equity Defined Protection ETF - 2 Yr to July 2026

Historical Prices for Innovator Equity Defined Protection ETF - 2 Yr to July 2026 Loading.. Sustainability Rating Copyright © 2026 Insider Inc and finanzen.net GmbH ...
Business Insider

iShares Core High Dividend ETF

Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Business Insider

S&P 500 Markets Movers

Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...

Imviva Biotech to Present Data from Clinical Studies of CTA313 and CTD402 Validating its ANSWER™ Allogeneic CAR-T Platform in Pediatric and Adult Patient Populations at EULAR ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational ...

FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs. “This draft guidance not only ...

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes

Enables dosing at the start of a meal, offering flexibility for children and adolescents as they manage school, sports, meals, and snacks ...

Hypersonic Spending Surge Brings A New Wave Of Defense Execution Talent Into The Commercial Space Race

Issued on behalf of Starfighters Space, Inc.As Washington pours capital into hypersonic test infrastructure and missile defense modernization, ...

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...